logo
Landmark genetic study aims to find root cause of debilitating disease

Landmark genetic study aims to find root cause of debilitating disease

9 News29-07-2025
Your web browser is no longer supported. To improve your experience update it here Australian researchers are launching a landmark study to identify the genetic cause of multiple sclerosis (MS). MS impacts more than 33,000 people in Australia however the exact cause of the disease remains unclear. While it is believed DNA, environmental factors and a common virus known as Epstein-Barr could trigger MS, scientists at University of South Australia are investigating the "biology" behind a person's risk of developing it. MS impacts more than 33,000 people in Australia however the exact cause of the disease remains unclear. (Getty) MS is a central nervous system autoimmune condiiton which impacts muscles and can result in fatigue, difficulty walking, loss of balance and pain. According to MS Australia, symptoms can be "varied and unpredictable". The university will conduct an Australian-first study using a method known as "recall by genotype" to explore the genetic causes of MS. The research could uncover how the Epstein-Barr virus leads to MS in some people but not in others. "For many years we've known that the Epstein-Barr virus is a likely precursor for MS," said lead researcher Dr David Stacey said. "But because the virus affects up to 90% of the population, it's difficult to pin down why some people go on to develop MS while others don't. "We believe the way a person's immune system responds to the Epstein-Barr virus may be a key factor, and genetics can help us uncover that." The study will involve over calculating the genetic risk scores for over 1000 participants from South Australia who have not been diagnosed with MS. It will then compare traits against those with a high or low risk. "By grouping people based on their genetic profile, we expect to find those with a high genetic risk for MS will also show biological differences – even if they don't have the disease," Dr Stacey added. "That could reveal how the Epstein-Barr virus and MS are connected and identify early warning signs or biomarkers for MS." The university will conduct an Australian-first study using a method known as "recall by genotype" to explore the genetic causes of MS. (Getty) The 'recall by genotype' method used in this study will guide other researchers to establish standards operating procedures in similar genetic studies. Dr Stacey said it will help tackle ethical questions regarding sharing genetic risk information with patients. "If we identify people who are at risk of developing MS, we need to consider how – and whether – to share that information, particularly as this information may not yet be clinically actionable," Dr Stacey said. "This study will explore those ethical, legal and social questions to guide how future studies approach personal genetic risk." It's hoped the study will help support early diagnostic tools and preventative strategies for MS. health
Australia
national
Research
Study
South Australia CONTACT US
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

‘A very big threat': Australia defends PBS as Trump flags 250% tariffs on medicines
‘A very big threat': Australia defends PBS as Trump flags 250% tariffs on medicines

Sydney Morning Herald

time8 hours ago

  • Sydney Morning Herald

‘A very big threat': Australia defends PBS as Trump flags 250% tariffs on medicines

Health Minister Mark Butler is planning to speed up medicines approvals as United States President Donald Trump threatens to put tariffs of up to 250 per cent on pharmaceutical products, which could affect $2 billion worth of Australian exports. Butler said Trump's latest threat would not change the discount Australians received on medicines through the Pharmaceutical Benefits Scheme, but revealed he would get advice within days about accelerating the approvals process for new drugs in Australia – a key issue that US pharmaceutical giants have raised with Trump. Speeding up the timeframe for US medicines to land on pharmacy shelves could improve the Australian government's standing with the Trump administration, although it does not deal with the White House's bigger concern that Americans pay more for medicines than citizens of other countries. Trump's anger with what he called 'foreign freeloading nations' prompted him to threaten tariffs of up to 250 per cent on drug imports this week. Butler said it was a 'a very big threat'. 'It's one we're working very hard to engage with the Americans on,' Butler said on Thursday. Loading 'The numbers are jumping around … They were 200 per cent a couple of weeks ago, and now they're 250 per cent potentially. They are very, very big tariffs. 'We are making the case very strongly, but I'm not going to pretend that the US Administration doesn't appear to be pretty serious about this.' Australia's PBS – under which the government subsidises drugs and Australians can buy expensive medicines for a maximum price of $31.60, soon to become $25 – has been brought up repeatedly during Trump's trade wars as US pharmaceutical companies push the president to punish countries that limit their market access.

‘A very big threat': Australia defends PBS as Trump flags 250% tariffs on medicines
‘A very big threat': Australia defends PBS as Trump flags 250% tariffs on medicines

The Age

time8 hours ago

  • The Age

‘A very big threat': Australia defends PBS as Trump flags 250% tariffs on medicines

Health Minister Mark Butler is planning to speed up medicines approvals as United States President Donald Trump threatens to put tariffs of up to 250 per cent on pharmaceutical products, which could affect $2 billion worth of Australian exports. Butler said Trump's latest threat would not change the discount Australians received on medicines through the Pharmaceutical Benefits Scheme, but revealed he would get advice within days about accelerating the approvals process for new drugs in Australia – a key issue that US pharmaceutical giants have raised with Trump. Speeding up the timeframe for US medicines to land on pharmacy shelves could improve the Australian government's standing with the Trump administration, although it does not deal with the White House's bigger concern that Americans pay more for medicines than citizens of other countries. Trump's anger with what he called 'foreign freeloading nations' prompted him to threaten tariffs of up to 250 per cent on drug imports this week. Butler said it was a 'a very big threat'. 'It's one we're working very hard to engage with the Americans on,' Butler said on Thursday. Loading 'The numbers are jumping around … They were 200 per cent a couple of weeks ago, and now they're 250 per cent potentially. They are very, very big tariffs. 'We are making the case very strongly, but I'm not going to pretend that the US Administration doesn't appear to be pretty serious about this.' Australia's PBS – under which the government subsidises drugs and Australians can buy expensive medicines for a maximum price of $31.60, soon to become $25 – has been brought up repeatedly during Trump's trade wars as US pharmaceutical companies push the president to punish countries that limit their market access.

Sunrise's Nat and Shirvo shocked to meet Daisy, the ‘woman' set to solve the aged care workforce shortage
Sunrise's Nat and Shirvo shocked to meet Daisy, the ‘woman' set to solve the aged care workforce shortage

7NEWS

time8 hours ago

  • 7NEWS

Sunrise's Nat and Shirvo shocked to meet Daisy, the ‘woman' set to solve the aged care workforce shortage

Sunrise's Nat Barr and Matt Shirvington have seen almost everything but the TV hosts were somewhat flabbergasted by one guest on Thursday. Daisy is an AI-powered robot who is set to solve the staffing shortage currently facing Australian nursing homes and aged care industry. Described as a 'cutting-edge humanoid', Daisy can lead tai chi and mahjong classes, recite poetry, and have conversations with people. Developed by Singaporean social robotics provider Dex-Lab, Daisy is not meant to replace aged care workers, only assist in duties — at least for now — according to the Australian Nursing Home Foundation. Nat and Shirvo looked somewhat taken aback as they spoke with Daisy, asking her a number of questions. Barr asked: 'Daisy, what do you like about working in aged care?' Daisy replied: 'I love hearing life stories, sharing laughter, and helping seniors feel connected. It is heartwarming to be part of their daily joy. Even if I can't get hugs, I can always give smiles.' Shirvo then asked: 'Daisy, what we love most about aged care is singing and dancing. Can you sing us a song?' Daisy: 'I would love to but my operator needs to switch the mode on the tablet. Right now, we can chat away.' Barr asked Daisy what she thought of the Sunrise studio. Daisy replied: 'It is so vibrant and lively here. The energy is fantastic. It makes me even more excited to be here in Australia.' The robot finished by demonstrating a dance. Australia is facing a shortfall of more than 70,000 nurses by 2035, according to The Department of Health and Aged Care's Nursing Supply and Demand Study. Australian Nursing Home Foundation CEO Ada Cheng explained Daisy could help fill some of the gaps in aged care facilities. 'Daisy is wonderful. Since she has come, she is singing and dancing with the elderly, doing exercises, and she is also very good in one-on-one talking — always patient, always encouraging,' Cheng said. 'All people love to talk to her because she is not replacing our staff, she is supporting our staff.' Cheng explained Daisy was a 'very knowledgeable lady' who can lead group exercises, freeing up qualified human staff for 'one-on-one support' for individuals who need it. She was also a 'very good support tool' because she can also lead singalongs and karaoke, enabling human staff to attend to other duties — or even have a deserved break.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store